Clinical Trial Update: A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for lidocaine 5% medicated plaster in postherpetic neuralgia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• Lidocaine 5% medicated plaster (lidocaine)

Snippet

Sponsor: Grünenthal GmbH | Conditions: Post Herpetic Neuralgia | Phase 3 | Status: COMPLETED